In response to Bergonzi et al.: Azacitidine–ruxolitinib combination therapy may permit dose reduction in VEXAS syndrome

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jeremiah Tan, Natasha Dehghan, Luke Y. C. Chen
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet